Deep learning's false positive burden may threaten the MRI harm reduction mandate in screening.

Abstract

Authors

• Anwar R Padhani
  From the Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, England (A.R.P.); and Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Md (B.T.).
• Nikolaos Papanikolaou
  Computational Biomedicine Laboratory (CBML), Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece.

Keywords

No keywords available for this article.

External Resources